MyThings snags $5M to keep track of your stuff
Anyone who has dug through their inbox for online purchase receipts or tracking numbers — or forgotten that they even bought something that never showed up — will likely have built-in appreciation for the concept behind MyThings, a web service that keeps track of what you buy and the clutter of email that comes with it. The London-based company just raked in $5 million in second-round financing, but hasn’t yet disclosed what it will be… Continue Reading
Life sciences briefing: Thursday, Oct. 4, 2007
Featured companies: 23andMe, APT Pharmaceuticals, Hyperion Therapeutics, Isis Biopolymer, Virogenomics
UPDATED at 10:30am PT.
APT Pharma raises $22M for transplant and heart drugs — Burlingame, Calif.’s APT Pharmaceuticals, a specialty pharma currently focused on a drug to fight organ-transplant rejection, raised $22 million in an extension of its first funding round. Investors included Versant Ventures, Great Point Partners, Vivo Ventures and Charter Life Sciences.
APT, which acquires its drug candidates instead of developing them itself, has raised a total of… Continue Reading